Abbvie Inc Stock Z Score
| ABBV Stock | USD 214.47 2.70 1.27% |
AbbVie |
AbbVie Inc Company Z Score Analysis
AbbVie's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
In accordance with the company's disclosures, AbbVie Inc has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and about the same as Health Care (which currently averages 0.0) industry. The z score for all United States stocks is 100.0% higher than that of the company.
AbbVie ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, AbbVie's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to AbbVie's managers, analysts, and investors.Environmental | Governance | Social |
AbbVie Institutional Holders
Institutional Holdings refers to the ownership stake in AbbVie that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of AbbVie's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing AbbVie's value.| Shares | Northern Trust Corp | 2024-12-31 | 21.8 M | Fmr Inc | 2024-12-31 | 18.1 M | Franklin Resources Inc | 2024-12-31 | 17.2 M | Capital World Investors | 2024-12-31 | 16.4 M | Bank Of New York Mellon Corp | 2024-12-31 | 13.7 M | Ameriprise Financial Inc | 2024-12-31 | 13 M | Ubs Group Ag | 2024-12-31 | 12.6 M | Ubs Asset Mgmt Americas Inc | 2024-12-31 | 12.1 M | Legal & General Group Plc | 2024-12-31 | 11.6 M | Vanguard Group Inc | 2024-12-31 | 173.1 M | Blackrock Inc | 2024-12-31 | 142 M |
AbbVie Fundamentals
| Return On Equity | 0.62 | ||||
| Return On Asset | 0.0826 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.33 % | ||||
| Current Valuation | 435.44 B | ||||
| Shares Outstanding | 1.77 B | ||||
| Shares Owned By Insiders | 0.11 % | ||||
| Shares Owned By Institutions | 74.02 % | ||||
| Number Of Shares Shorted | 18.51 M | ||||
| Price To Earning | 21.28 X | ||||
| Price To Book | 112.44 X | ||||
| Price To Sales | 6.64 X | ||||
| Revenue | 56.33 B | ||||
| Gross Profit | 39.61 B | ||||
| EBITDA | 14.91 B | ||||
| Net Income | 4.29 B | ||||
| Cash And Equivalents | 11.88 B | ||||
| Cash Per Share | 6.72 X | ||||
| Total Debt | 67.14 B | ||||
| Debt To Equity | 4.37 % | ||||
| Current Ratio | 0.93 X | ||||
| Book Value Per Share | 1.88 X | ||||
| Cash Flow From Operations | 18.81 B | ||||
| Short Ratio | 3.08 X | ||||
| Earnings Per Share | 2.39 X | ||||
| Price To Earnings To Growth | 0.44 X | ||||
| Target Price | 211.73 | ||||
| Number Of Employees | 55 K | ||||
| Beta | 0.6 | ||||
| Market Capitalization | 373.85 B | ||||
| Total Asset | 135.16 B | ||||
| Retained Earnings | (7.9 B) | ||||
| Working Capital | (13.17 B) | ||||
| Current Asset | 16.31 B | ||||
| Current Liabilities | 10.89 B | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 4.33 % | ||||
| Net Asset | 135.16 B | ||||
| Last Dividend Paid | 6.29 |
About AbbVie Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AbbVie Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AbbVie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AbbVie Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.